Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email or telephone.
Central Media Line:Phone: +41 61 324 2200
This site is intended for a global audience.